Linxi Yang
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- RNA modifications and cancer
- Cancer-related gene regulation
- Epigenetics and DNA Methylation
- RNA Research and Splicing
- Circular RNAs in diseases
Papers in
-
- Gastrointestinal Tumor Research and Treatment 10
-
- Metastasis and carcinoma case studies 4
- Gastric Cancer Management and Outcomes 4
- Co-authors
- Ben Yue (2 shared papers)Zizhen Zhang (2 shared papers)Ran Cui (1 shared paper)Gang Zhao (1 shared paper)Chenlong Song (1 shared paper)Bo Ni (8 shared papers)Lin Tu (8 shared papers)Xinli Ma (6 shared papers)
- Journals
- Journal of Clinical Oncology (1 paper)Frontiers in Oncology (1 paper)Cancer Letters (1 paper)Diagnostic Pathology (1 paper)Theranostics (1 paper)
- Partner nations
- China
In The Last Decade
Linxi Yang
14 papers receiving 529 citations
Hit Papers
Peers
Comparison fields: 5 of 45
- Cancer Research 292
- Molecular Biology 469
- Gastroenterology 18
- Oncology 65
- Pulmonary and Respiratory Medicine 46
Countries citing papers authored by Linxi Yang
This map shows the geographic impact of Linxi Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linxi Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linxi Yang more than expected).
Fields of papers citing papers by Linxi Yang
This network shows the impact of papers produced by Linxi Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linxi Yang. The network helps show where Linxi Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Linxi Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer Hit paper breakdown → | 2019 | 463 |
| 2 | 2019 | 17 | |
| 3 | 2022 | 11 | |
| 4 | 2019 | 11 | |
| 5 | 2024 | 6 | |
| 6 | 2021 | 4 | |
| 7 | 2020 | 4 | |
| 8 | 2022 | 4 | |
| 9 | 2023 | 4 | |
| 10 | 2023 | 1 | |
| 11 | 2019 | 1 | |
| 12 | 2021 | 1 | |
| 13 | Long noncoding RNA SPRY4-IT1 acts as a miR-101-5p sponge to promote gastrointestinal stromal tumor progression by inhibiting ZEB1. | 2023 | 1 |
| 14 | 2020 | 1 | |
| 15 | 2025 | 0 |
About Linxi Yang
Linxi Yang is a scholar working on Gastroenterology, Pulmonary and Respiratory Medicine, Molecular Biology, Surgery and Pathology and Forensic Medicine, having authored 15 papers that have together received 529 indexed citations. Recurring topics across this work include Gastrointestinal Tumor Research and Treatment (10 papers), Metastasis and carcinoma case studies (4 papers), Gastric Cancer Management and Outcomes (4 papers), Neurofibromatosis and Schwannoma Cases (2 papers), RNA modifications and cancer (2 papers), Cancer-related molecular mechanisms research (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Cancer Research (292 citations), Molecular Biology (469 citations), Gastroenterology (18 citations), Oncology (65 citations) and Pulmonary and Respiratory Medicine (46 citations). Linxi Yang has collaborated with scholars based in China. Frequent co-authors include Ben Yue, Zizhen Zhang, Ran Cui, Gang Zhao, Chenlong Song, Bo Ni, Lin Tu, Xinli Ma, Hui Cao and Wenyi Zhao. Their work appears in journals such as Journal of Clinical Oncology, Frontiers in Oncology, Cancer Letters, Diagnostic Pathology and Theranostics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.